NSE - Delayed Quote INR
Alivus Life Sciences Limited (ALIVUS.NS)
1,115.60
+9.50
+(0.86%)
At close: May 9 at 3:29:56 PM GMT+5:30
Research Analysis
Earnings Estimate
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 3 | 4 |
Avg. Estimate | 10 | 0 | 39.17 | 49.58 |
Low Estimate | 10 | 0 | 38.4 | 46.9 |
High Estimate | 10 | 0 | 40.1 | 54.6 |
Year Ago EPS | 7.97 | 9.08 | 38.38 | 39.17 |
Revenue Estimate
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | -- | 3 | 4 |
Avg. Estimate | 6.23B | -- | 24.06B | 28.1B |
Low Estimate | 6.14B | -- | 23.7B | 27.37B |
High Estimate | 6.33B | -- | 24.67B | 28.99B |
Year Ago Sales | 5.37B | -- | 22.83B | 24.06B |
Sales Growth (year/est) | 16.19% | -- | 5.38% | 16.81% |
Earnings History
Currency in INR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 10.4 | 9 | 10 | 10 |
EPS Actual | 7.97 | 9.08 | 7.75 | 11.14 |
Difference | -2.43 | 0.08 | -2.25 | 1.14 |
Surprise % | -23.37% | 0.89% | -22.50% | 11.40% |
EPS Trend
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 10 | 0 | 39.17 | 49.58 |
7 Days Ago | 0 | 0 | 39.05 | 49.24 |
30 Days Ago | 0 | 0 | 39.05 | 49.35 |
60 Days Ago | 0 | 0 | 39.96 | 49.43 |
90 Days Ago | 0 | 0 | 40.41 | 48.62 |
EPS Revisions
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 2 | 2 |
Up Last 30 Days | -- | -- | 2 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ALIVUS.NS | 25.47% | -- | 2.05% | 26.57% |
S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Related Tickers
4559.T Zeria Pharmaceutical Co., Ltd.
2,176.00
-6.57%
ERIS.NS Eris Lifesciences Limited
1,456.00
-0.65%
STAR.NS Strides Pharma Science Limited
638.45
+0.50%
EMCURE.NS EMCURE PHARMACEUTICALS L
1,007.60
-1.53%
CAPLIPOINT.NS Caplin Point Laboratories Limited
1,860.90
-2.15%
MANKIND.NS Mankind Pharma Limited
2,408.20
-1.28%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,398.20
-1.46%